Abstract

ObjectivesRecently, incidence of Mycobacterium abscessus (Mab) pulmonary disease (Mab-PD) is increasing worldwide. We aimed to identify factors associated with severity of Mycobacterium abscessus (Mab) pulmonary disease (Mab-PD).MethodsAll patients diagnosed as Mab-PD based on the official ATS/IDSA statement between 2017 January 1 and 2021 July 31 were included (n = 13). We reviewed medical records, bacteriological and laboratory data of the patients. Severity of lung lesions and esophageal diameters in chest CT were quantitatively evaluated. Gaffky score in the sputum was used as airway mycobacterial burden. We explored the factors associated with high CT score and high Gaffky score.ResultsMaximum diameter of esophagus (MDE) in severe disease (CT score≧10) was greater than that in milder disease (CT score<10) (18.0±7.9mm, 9.3±3.1mm, respectively, p = 0.01), and MDE was well correlated with CT score (R = 0.69, p = 0.007). MDE in high mycobacterial burden group (Gaffky score ≧5) tended to be greater than that in low mycobacterial burden group (Gaffky score <5) (16.1±6.8mm, 10.1±5.5mm, respectively, p = 0.12), and MDE was well correlated with Gaffky score (R = 0.68, p = 0.009). Lung lesions were bilateral and predominant in middle or lower lobes.ConclusionsEsophageal dilatation was correlated with severity of Mab-PD and airway mycobacterial burden. Gastroesophageal reflux might be associated with Mab disease progression.

Highlights

  • Mycobacterium abscessus (Mab) is one of rapidly growing non-tuberculous mycobacteria (NTM) [1]

  • Esophageal dilatation was correlated with severity of Mab-Pulmonary disease (PD) and airway mycobacterial burden

  • Gastroesophageal reflux might be associated with Mab disease progression

Read more

Summary

Introduction

Mycobacterium abscessus (Mab) is one of rapidly growing non-tuberculous mycobacteria (NTM) [1]. In comparison to M.avium complex(MAC), Mab is less commonly isolated from respiratory specimens [4], clinical characteristics of Mycobacterium abscessus (Mab) pulmonary disease (Mab-PD) remains to be elucidated. Incidence of Mab-PD is increasing worldwide including Japan [4,5]. The incidence rate for Mab-PD increased from 0.1 cases in 2001 to 0.5 cases per 100000 personyears in 2014 in Japan [5]. Mab-PD is becoming an important public health problem, and there is an urgent need for elucidating clinical characteristics and the risk factors for Mab-PD exacerbation to diagnose in early stage and prevent progression of the disease

Objectives
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.